IL131892A0 - 6, 7-Disubstituted-4-aminopyrido [2, 3-d] pyrimidine compounds - Google Patents

6, 7-Disubstituted-4-aminopyrido [2, 3-d] pyrimidine compounds

Info

Publication number
IL131892A0
IL131892A0 IL13189298A IL13189298A IL131892A0 IL 131892 A0 IL131892 A0 IL 131892A0 IL 13189298 A IL13189298 A IL 13189298A IL 13189298 A IL13189298 A IL 13189298A IL 131892 A0 IL131892 A0 IL 131892A0
Authority
IL
Israel
Prior art keywords
aminopyrido
disubstituted
pyrimidine compounds
pyrimidine
compounds
Prior art date
Application number
IL13189298A
Other languages
English (en)
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of IL131892A0 publication Critical patent/IL131892A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL13189298A 1997-04-16 1998-04-16 6, 7-Disubstituted-4-aminopyrido [2, 3-d] pyrimidine compounds IL131892A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83439397A 1997-04-16 1997-04-16
PCT/US1998/004127 WO1998046603A1 (en) 1997-04-16 1998-04-16 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds

Publications (1)

Publication Number Publication Date
IL131892A0 true IL131892A0 (en) 2001-03-19

Family

ID=25266829

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13189298A IL131892A0 (en) 1997-04-16 1998-04-16 6, 7-Disubstituted-4-aminopyrido [2, 3-d] pyrimidine compounds

Country Status (20)

Country Link
EP (1) EP0979230A1 (xx)
JP (1) JP2001520649A (xx)
KR (1) KR20010006453A (xx)
CN (1) CN1259948A (xx)
AR (1) AR012435A1 (xx)
AU (1) AU744528B2 (xx)
BG (1) BG103861A (xx)
BR (1) BR9809088A (xx)
CA (1) CA2287465A1 (xx)
CO (1) CO4940439A1 (xx)
HU (1) HUP0001402A3 (xx)
IL (1) IL131892A0 (xx)
NO (1) NO995033L (xx)
NZ (1) NZ337844A (xx)
PL (1) PL336262A1 (xx)
SK (1) SK142099A3 (xx)
TR (1) TR199902456T2 (xx)
TW (1) TW458977B (xx)
WO (1) WO1998046603A1 (xx)
ZA (1) ZA982912B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001057040A1 (en) * 2000-02-03 2001-08-09 Abbott Laboratories 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
PL366918A1 (en) * 2001-02-12 2005-02-07 F.Hoffmann-La Roche Ag 6-substituted pyrido-pyrimidines
KR20070086076A (ko) 2004-11-12 2007-08-27 트러스티즈 오브 터프츠 칼리지 리파아제 억제제
EP2139332A4 (en) * 2007-03-28 2010-04-21 Merck Sharp & Dohme SUBSTITUTED PYRIDO [2,3-D] PYRIMIDINE DERIVATIVES AS CANNABINOID-1 RECEPTOR MODULATORS
BR112015007182A2 (pt) * 2012-10-05 2017-07-04 Rigel Pharmaceuticals Inc inibidores de gdf-8
WO2017205848A1 (en) * 2016-05-27 2017-11-30 Legacy Emanuel Hospital & Health Center Methanocarba derivatives of pseudoribose that inhibit adenosine kinase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB774094A (en) * 1953-01-02 1957-05-08 Wellcome Found Improvements in or relating to pyrimidine compounds
IL112249A (en) * 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds

Also Published As

Publication number Publication date
TW458977B (en) 2001-10-11
KR20010006453A (ko) 2001-01-26
AU744528B2 (en) 2002-02-28
PL336262A1 (en) 2000-06-19
ZA982912B (en) 1998-10-09
BG103861A (en) 2000-06-30
AR012435A1 (es) 2000-10-18
EP0979230A1 (en) 2000-02-16
TR199902456T2 (xx) 2000-07-21
BR9809088A (pt) 2000-08-01
CN1259948A (zh) 2000-07-12
NO995033D0 (no) 1999-10-15
SK142099A3 (en) 2000-05-16
NZ337844A (en) 2001-11-30
CO4940439A1 (es) 2000-07-24
JP2001520649A (ja) 2001-10-30
NO995033L (no) 1999-12-15
HUP0001402A2 (hu) 2000-10-28
CA2287465A1 (en) 1998-10-22
HUP0001402A3 (en) 2001-01-29
AU7098198A (en) 1998-11-11
WO1998046603A1 (en) 1998-10-22

Similar Documents

Publication Publication Date Title
IL139598A0 (en) PYRROLO [2,3-d] PYRIMIDINE COMPOUNDS
PL345123A1 (en) Pyrrolo[2,3-d]pyrimidine compounds
EG24399A (en) Pyrrolo[2,3-D]pyrimidine compounds
IL125358A0 (en) 5H-thiazolo [3,2-a] pyrimidine derivatives
HK1069577A1 (en) Pyrazolo [4,3-D] pyrimidine derivatives
AU1794697A (en) 7-alkyl-pyrrolo{2,3-d}pyrimidines
PL353366A1 (en) Pyrazolo[4,3-d]pyrimidines
ZA983177B (en) 5,7-Disubstituted-4-aminopyrdo [2,3] pyrimidine compounds
GB9506309D0 (en) Pyrimidine compounds
IL136500A0 (en) 1,4-diazacycloheptane derivatives
IL131892A0 (en) 6, 7-Disubstituted-4-aminopyrido [2, 3-d] pyrimidine compounds
PL336265A1 (en) 5,6,7-trisubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
EP0904271A4 (en) 5,6,7,8-tetrahydropyrido [2,3-d] PYRIMIDINE
ZA994004B (en) Pyrrolo[2,3-d]pyrimidine compounds.
SI1087970T1 (en) PYRROLO 2,3-d)PYRIMIDINE COMPOUNDS
GB2316077B (en) Pyrimidine Compounds
AU3500997A (en) 5,6,7,8-tetrahydropyrido{2,3-d}pyrimidine derivatives
SI1210349T1 (en) PYRAZOLO 4,3-d)PYRIMIDINES
EP0954316A4 (en) PYRIMIDINE DERIVATIVES